Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 7, Number 12, December 2009

Free Content The molecular basis of factor V and VIII procofactor activation
pp. 1951-1961(11)
Authors: CAMIRE, R. M.; BOS, M. H. A.

Favourites:
ADD

Free Content Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?
pp. 1962-1971(10)
Authors: WILLEMSE, J. L.; HEYLEN, E.; NESHEIM, M. E.; HENDRIKS, D. F.

Favourites:
ADD

Free Content Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study
pp. 1972-1978(7)
Authors: CARCAILLON, L.; GAUSSEM, P.; DUCIMETIÈRE, P.; GIROUD, M.; RITCHIE, K.; DARTIGUES, J. F.; SCARABIN, P. Y.

Favourites:
ADD
Favourites:
ADD

Free Content Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy
pp. 1982-1989(8)
Authors: WITT, D. M.; DELATE, T.; MCCOOL, K. H.; DOWD, M. B.; CLARK, N. P.; CROWTHER, M. A.; GARCIA, D. A.; AGENO, W.; DENTALI, F.; HYLEK, E. M.; RECTOR, W. G.

Favourites:
ADD

Free Content Evaluation of children with a suspected bleeding disorder applying the Impact-R [Cone and Plate(let) Analyzer]
pp. 1990-1996(7)
Authors: REVEL-VILK, S.; VARON, D.; SHAI, E.; AGMON, Y.; HYAM, E.; DAAS, N.; MISKIN, H.; WEINTRAUB, M.

Favourites:
ADD

Free Content Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy
pp. 1997-2005(9)
Authors: MANCUSO, M. E.; RUMI, M. G.; AGHEMO, A.; SANTAGOSTINO, E.; PUOTI, M.; COPPOLA, A.; COLOMBO, M.; MANNUCCI, P. M.

Favourites:
ADD

Free Content Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-α and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A
pp. 2006-2015(10)
Authors: PAVLOVA, A.; DELEV, D.; LACROIX-DESMAZES, S.; SCHWAAB, R.; MENDE, M.; FIMMERS, R.; ASTERMARK, J.; OLDENBURG, J.

Favourites:
ADD
Favourites:
ADD

Free Content Warfarin use and the risk of valvular calcification
pp. 2023-2027(5)
Authors: LERNER, R. G.; ARONOW, W. S.; SEKHRI, A.; PALANISWAMY, C.; AHN, C.; SINGH, T.; SANDHU, R.; McCLUNG, J. A.

Favourites:
ADD

Free Content Comparison of the clinical history of symptomatic isolated distal deep-vein thrombosis vs. proximal deep vein thrombosis in 11 086 patients
pp. 2028-2034(7)
Authors: GALANAUD, J. P.; QUENET, S.; RIVRON-GUILLOT, K.; QUERE, I.; SANCHEZ MUÑOZ-TORRERO, J. F.; TOLOSA, C.; MONREAL, M.

Favourites:
ADD

Free Content Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study
pp. 2035-2041(7)
Authors: GIBSON, N. S.; SCHELLONG, S. M.; KHEIR, D. Y. El; BEYER-WESTENDORF, J.; GALLUS, A. S.; MCRAE, S.; SCHUTGENS, R. E. G.; PIOVELLA, F.; GERDES, V. E. A.; BULLER, H. R.

Favourites:
ADD

Free Content Cost-effectiveness of ruling out deep venous thrombosis in primary care versus care as usual
pp. 2042-2049(8)
Authors: TEN CATE-HOEK, A. J.; TOLL, D. B.; BÜLLER, H. R.; HOES, A. W.; MOONS, K. G. M.; OUDEGA, R.; STOFFERS, H. E. J. H.; van der VELDE, E. F.; van WEERT, H. C. P. M.; PRINS, M. H.; JOORE, M. A.

Favourites:
ADD
Favourites:
ADD

Free Content Direct effects of protein S in ameliorating acute lung injury
pp. 2053-2063(11)
Authors: TAKAGI, T.; TAGUCHI, O.; AOKI, S.; TODA, M.; YAMAGUCHI, A.; FUJIMOTO, H.; BOVEDA-RUIZ, D.; GIL-BERNABE, P.; RAMIREZ, A. Y.; NAITO, M.; YANO, Y.; D'ALESSANDRO-GABAZZA, C. N.; FUJIWARA, A.; TAKEI, Y.; MORSER, J.; GABAZZA, E. C.

Favourites:
ADD

Free Content Pharmacokinetics and safety of fibrinogen concentrate
pp. 2064-2069(6)
Authors: MANCO-JOHNSON, M. J.; DIMICHELE, D.; CASTAMAN, G.; FREMANN, S.; KNAUB, S.; KALINA, U.; PEYVANDI, F.; PISEDDU, G.; MANNUCCI, P.

Favourites:
ADD

Free Content Platelet tetraspanins: small but interesting
pp. 2070-2073(4)
Author: TOMLINSON, M. G.

Favourites:
ADD

Free Content A platelet tetraspanin superfamily member, CD151, is required for regulation of thrombus growth and stability in vivo
pp. 2074-2084(11)
Authors: ORLOWSKI, E.; CHAND, R.; YIP, J.; WONG, C.; GOSCHNICK, M. W.; WRIGHT, M. D.; ASHMAN, L. K.; JACKSON, D. E.

Favourites:
ADD

Free Content Circulating ADAMTS-13–von Willebrand factor complexes: an enzyme on demand
pp. 2085-2087(3)
Authors: CRAWLEY, J. T. B.; DE GROOT, R.; LUKEN, B. M.

Favourites:
ADD

Free Content Multi-step binding of ADAMTS-13 to von Willebrand factor
pp. 2088-2095(8)
Authors: FEYS, H. B.; ANDERSON, P. J.; VANHOORELBEKE, K.; MAJERUS, E. M.; SADLER, J. E.

Favourites:
ADD

Free Content Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis
pp. 2096-2105(10)
Authors: BALDAUF, C.; SCHNEPPENHEIM, R.; STACKLIES, W.; OBSER, T.; PIECONKA, A.; SCHNEPPENHEIM, S.; BUDDE, U.; ZHOU, J.; GRÄTER, F.

Favourites:
ADD

Free Content Genetics of platelet reactivity in normal, healthy individuals
pp. 2116-2122(7)
Authors: KUNICKI, T. J.; WILLIAMS, S. A.; SALOMON, D. R.; HARRISON, P.; CRISLER, P.; NAKAGAWA, P.; MONDALA, T. S.; HEAD, S. R.; NUGENT, D. J.

Favourites:
ADD

Free Content Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia
pp. 2131-2136(6)
Authors: NORIS, P.; KLERSY, C.; ZECCA, M.; ARCAINI, L.; PECCI, A.; MELAZZINI, F.; TERULLA, V.; BOZZI, V.; AMBAGLIO, C.; PASSAMONTI, F.; LOCATELLI, F.; BALDUINI, C. L.

Favourites:
ADD

Free Content Aggregated low density lipoprotein induces tissue factor by inhibiting sphingomyelinase activity in human vascular smooth muscle cells
pp. 2137-2146(10)
Authors: CAMINO-LÓPEZ, S.; BADIMON, L.; GONZÁLEZ, A.; CANALS, D.; PEÑA, E.; LLORENTE-CORTÉS, V.

Favourites:
ADD

Free Content Association between genetic variation at the ADAMTS13 locus and ischemic stroke
pp. 2147-2148(2)
Authors: HANSON, E.; JOOD, K.; NILSSON, S.; BLOMSTRAND, C.; JERN, C.

Favourites:
ADD

Free Content Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient?
pp. 2149-2150(2)
Authors: GÓMEZ-OUTES, A.; SUÁREZ-GEA, Ma. L.; BLÁZQUEZ-PÉREZ, A.; POZO-HERNÁNDEZ, C.; VARGAS-CASTRILLÓN, E.

Favourites:
ADD

Free Content Variation in anticoagulant composition regulates differential effects of prothrombin complex concentrates on thrombin generation
pp. 2154-2156(3)
Authors: GILMORE, R.; HARMON, S.; KEANE, G.; GANNON, C.; O'DONNELL, J. S.

Favourites:
ADD

Free Content Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time: a rebuttal
pp. 2157-2157(1)
Authors: KITCHEN, S.; PRESTON, F. E.; JENNINGS, I.; KITCHEN, D.P.; WOODS, T.A.L.; WALKER, I.

Favourites:
ADD

Free Content International Society for Fibrinolysis and Proteolysis
pp. 2160-2160(1)
Authors: MEDCALF, R. L.; LIJNEN, R.

Favourites:
ADD

Free Content Join ISTH
pp. 2161-2161(1)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more